Unanswered questions following reports of secondary malignancies after CAR-T cell therapy.
Levine BL, Pasquini MC, Connolly JE, Porter DL, Gustafson MP, Boelens JJ, Horwitz EM, Grupp SA, Maus MV, Locke FL, Ciceri F, Ruggeri A, Snowden J, Heslop HE, Mackall CL, June CH, Sureda AM, Perales MA.
Levine BL, et al. Among authors: grupp sa.
Nat Med. 2024 Feb;30(2):338-341. doi: 10.1038/s41591-023-02767-w.
Nat Med. 2024.
PMID: 38195751
Free PMC article.